Press Release May 11, 2021

The Capital Markets Team Advises Underwriters in Privia Health’s Initial Public Offering

The Capital Markets team advised the underwriters of Privia Health Group’s (Nasdaq: PRVA) initial public offering of 22,425,000 shares of common stock at a public offering price of $23.00 per share, which included 2,800,000 shares sold by the company and 16,700,000 shares sold by a selling stockholder, as well as the full exercise of the underwriters’ option to purchase an additional 2,925,000 shares from the Privia. The gross proceeds of the offering to the company and the selling stockholder were approximately $607.8 million before deducting underwriting commissions and estimated offering expenses, and including a concurrent private placement of 4,000,000 shares to Anthem, Inc. Privia’s shares began trading on Nasdaq on April 29, 2021 under the ticker symbol “PRVA.”

Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual settings.

The Goodwin team was led by Mitchell Bloom, Ben Marsh, Humza Bokhari, Kaitlin Carragher, Ally Gao, and included Joel Lehrer, Roger Cohen, Nikhil Sethi, Andrew Hess, Heath Ingram, Jake Osborn, Sarah Bock, Brittany McCants, Janet Andolina, Leon Peschel, Jacqueline Klosek, Peter LaVigne, and Ettore Santucci, with invaluable assistance from Nathan Needle.

For additional details on the offering, please read the press release.